BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/3/2021 11:45:55 AM | Browse: 543 | Download: 978
 |
Received |
|
2021-01-28 17:21 |
|
Peer-Review Started |
|
2021-01-29 02:29 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-05-02 01:15 |
|
Revised |
|
2021-05-13 15:32 |
|
Second Decision |
|
2021-08-02 02:49 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-08-02 06:45 |
|
Articles in Press |
|
2021-08-02 06:45 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-08-16 04:09 |
|
Typeset the Manuscript |
|
2021-09-01 01:27 |
|
Publish the Manuscript Online |
|
2021-09-03 11:45 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Chiara Viganò, Giacomo Mulinacci, Andrea Palermo, Donatella Barisani, Lorena Pirola, Maria Fichera, Pietro Invernizzi and Sara Massironi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Chiara Viganò, MD, Doctor, Doctor, Division of Gastroenterology and Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Via G. B. Pergolesi 33, Monza 20900, Italy. c.vigano@asst-monza.it |
| Key Words |
Inflammatory bowel disease; Ulcerative colitis; Crohn disease; COVID-19; SARS-CoV-2; Autoimmunity |
| Core Tip |
Severe acute respiratory syndrome coronavirus-2 pandemic has abruptly impacted the management of patients with chronic immune-mediated diseases such as inflammatory bowel diseases (IBD). In a setting of general uncertainty, gastroenterologists have faced the need to rapidly re-organize facilities and redefine priorities in IBD clinical management. With an enormous research effort, accumulating evidence is deepening our understanding of the multifaceted interaction of IBD care and coronavirus disease 19. Direct and indirect effects of the pandemic will be present for some time, it is, therefore, necessary to keep recommendations constantly updated. |
| Publish Date |
2021-09-03 11:45 |
| Citation |
Viganò C, Mulinacci G, Palermo A, Barisani D, Pirola L, Fichera M, Invernizzi P, Massironi S. Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future. World J Gastroenterol 2021; 27(33): 5520-5535 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i33/5520.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i33.5520 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
